K Number
K102580
Date Cleared
2011-03-03

(176 days)

Product Code
Regulation Number
888.3560
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The Vanquard® Cruciate Molded Poly Tibia is intended for: 1. Painful and disabled knee joint resulting from osteoarthritis, rheumatoid arthritis traumatic arthritis where one or more compartments are involved; 2. Failure of a previous joint replacement procedure 3. Correction of varus, valgus, or post traumatic deformity; 4. Correction or revision of unsuccessful osteotomy or arthrodesis. The device is a single use implant intended for use with bone cement.

Device Description

The Vanguard® Removable Molded Poly Tibia (also referred to as the Vanguard® Mono-Lock) is intended to replace the tibial articulating surface in a joint replacement and works in conjunction with previously cleared Vanguard® Knee Systems. There are three parts to the Vanguard® Removable Cruciate Molded Polyethylene Tibia component: the tibial plate (Co-Cr-Mo), tibial bearing (UHMWPE) and an insert (Ti-6AL-4V). The profile of the tibial plate is identical to that of the predicates. The stem geometry of the Vanguard® Removable Molded Poly Tibia is non modular and does not include the conical core geometry to house the female taper as the predicate K915132. The articulation surface is identical to the surface cleared in K060525.

AI/ML Overview

This document describes a 510(k) premarket notification for a medical device, the Vanguard® Removable Molded Poly Tibia, which is a knee prosthesis. The submission seeks to demonstrate substantial equivalence to previously cleared predicate devices.

Acceptance Criteria and Device Performance:

The primary "acceptance criteria" in a 510(k) submission for a device like this are centered around demonstrating substantial equivalence to existing legally marketed predicate devices. This means proving that the new device is as safe and effective as a predicate device. For this specific device, the key performance aspects relate to the mechanical properties and design.

Since this is a knee prosthesis, "performance" is largely assessed through non-clinical mechanical testing and comparison to predicates. There are no clinical performance metrics in terms of patient outcomes or diagnostic accuracy in the same way one might have for an AI/ML device.

Table of Acceptance Criteria and Reported Device Performance:

Acceptance Criteria (Implied by Substantial Equivalence to Predicates)Reported Device Performance (Summary)
Material Composition Equivalence: Materials used are identical or equivalent to predicates.The document explicitly states: "The technological characteristics (material, design, and sizing) of the Vanguard® Removable Molded Poly Tibia are identical to the predicate devices." (p.2/2) "The material... remain identical to the predicate devices." (p.2/2)
Design Equivalence (Articulation Surface): The articulating surface design is equivalent to predicates to ensure proper function and wear."The articulation surface is identical to the surface cleared in K060525." (p.1/2)
Tibial Plate Profile Equivalence: The overall profile of the tibial plate matches that of predicates."The profile of the tibial plate is identical to that of the predicates." (p.1/2)
Locking Mechanism Equivalence: The mechanism for securing the components is identical to predicates."The locking mechanism... remain identical to the predicate devices." (p.2/2)
Stem Design Performance (Fixed Cruciate vs. I-beam): The new fixed cruciate stem design performs equivalently to the predicate's fixed I-beam stem and other predicate designs.The key change noted is the stem design: "the new device has a fixed cruciate stem whereas the predicate has a fixed I-beam stem." (p.2/2) To address this, "The CoCr Cruciate Plate 80/20 Fatigue Test Report is also provided to further indicate the devices are functional within its intended use." (p.2/2) This suggests the acceptance criterion was mechanical equivalence in fatigue performance for the new stem design.
Mechanical Strength and Durability: The device withstands forces and fatigue for its intended lifespan, demonstrated through relevant mechanical tests."Mechanical testing was previously performed to determine substantial equivalence and the following test reports were provided in the predicate 510(k): CoCr I-Beam Tray 80/20 Fatique Test Report, Removable Molded Tibia PS Post Fatigue Strength, 10mm PS Component - Intercondylar Polyethylene Thickness Analysis, Vanguard Removable Retention Test. The CoCr Cruciate Plate 80/20 Fatigue Test Report is also provided to further indicate the devices are functional within its intended use." (p.2/2)
Sizing Equivalence: Additional sizes are consistent with existing predicate sizing and performance."Additional sizes to the tibial plate and bearing include 59mm, 87mm and 91mm, which are identical to the predicate devices in K915132." (p.2/2) This implies that the performance of these additional sizes is inherently covered by the existing predicate's characterization.
Intended Use Compatibility: The device is appropriate for the stated indications for use.The intended uses are listed on p.1/2 and p.4/5, aligning with typical knee replacement indications. The substantial equivalence argument supports that the device is safe and effective for these uses given its similarity to predicates.

Study Proving Device Meets Acceptance Criteria:

The study that proves the device meets the acceptance criteria is primarily non-clinical mechanical testing and a demonstration of design and material equivalence to predicate devices.

Specific Information Requested:

  1. Sample sizes used for the test set and the data provenance:

    • This submission relies on non-clinical mechanical testing rather than clinical data from human subjects. The "test set" would consist of physical device samples.
    • The document lists several "test reports" such as "CoCr I-Beam Tray 80/20 Fatique Test Report," "Removable Molded Tibia PS Post Fatigue Strength," etc.
    • The sample sizes for these specific mechanical tests are not explicitly stated in the provided text.
    • Data Provenance: The tests are indicated as having been "previously performed" (for predicates) and some new tests (e.g., CoCr Cruciate Plate 80/20 Fatigue Test Report) were "provided to further indicate the devices are functional within its intended use." This implies the testing was likely conducted in a lab setting by the manufacturer, Biomet Manufacturing Corp., or a contract lab. The country of origin for the testing data is not specified but would presumably be related to Biomet's operations (USA, given the address in Indiana). The data is retrospective in the sense that many tests leverage previous data from predicate devices.
  2. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

    • This question is less applicable to a mechanical device 510(k) submission based on substantial equivalence and non-clinical testing.
    • There is no "ground truth" in the clinical diagnostic sense established by human experts for a test set of patient data.
    • The "ground truth" for mechanical testing is established by engineering standards and specifications (e.g., ISO, ASTM standards for medical device mechanically), often with verification by qualified engineers and testing technicians. The number and qualifications of these individuals are not specified in the document.
  3. Adjudication method (e.g., 2+1, 3+1, none) for the test set:

    • Not applicable. This is a concept used in clinical trials or studies with human reader performance assessment, not for mechanical device testing for substantial equivalence. The "adjudication" of mechanical test results would typically refer to review by quality control/engineering personnel to ensure adherence to protocols and standards.
  4. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    • Not applicable. This is a mechanical device, not an AI/ML diagnostic tool. No MRMC study was performed.
  5. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

    • Not applicable. This is a mechanical device, not an AI/ML algorithm.
  6. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):

    • The "ground truth" is based on engineering specifications, mechanical performance standards (e.g., fatigue strength, retention strength), and comparison to the proven performance of predicate devices. It's about demonstrating mechanical integrity and functional equivalence, not clinical diagnostic accuracy or patient outcomes data directly.
  7. The sample size for the training set:

    • Not applicable in the context of an AI/ML device. For a traditional mechanical device, there isn't a "training set" in the machine learning sense. The "training" for such devices involves design iterations, material selection, and internal testing to optimize the product before formal verification tests.
  8. How the ground truth for the training set was established:

    • Not applicable for the reasons stated above. Design and R&D involve iterative testing, but not a formally defined "training set" with ground truth in the AI/ML context.

{0}------------------------------------------------

K102580
p1/2.

510(k) Summary

Preparation Date:January 3, 2010
Applicant/Sponsor:Biomet Manufacturing Corp.
Contact Person:Tamara West
Proprietary Name:Vanguard® Removable Molded Poly Tibia
Common Name:Knee Prosthesis
Classification Name:Knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis (21CFR §888.3560)

MAR - 3 2011

Legally Marketed Devices To Which Substantial Equivalence Is Claimed:

K060525Vanguard Removable Molded Poly TibiaBiomet Manufacturing Corp.
K915132MCK [Maxim] Knee SystemBiomet Manufacturing Corp.

Device Description:

The Vanguard® Removable Molded Poly Tibia (also referred to as the Vanguard® Mono-Lock) is intended to replace the tibial articulating surface in a joint replacement and works in conjunction with previously cleared Vanguard® Knee Systems. There are three parts to the Vanguard® Removable Cruciate Molded Polyethylene Tibia component: the tibial plate (Co-Cr-Mo), tibial bearing (UHMWPE) and an insert (Ti-6AL-4V).

The profile of the tibial plate is identical to that of the predicates. The stem geometry of the Vanguard® Removable Molded Poly Tibia is non modular and does not include the conical core geometry to house the female taper as the predicate K915132.

The articulation surface is identical to the surface cleared in K060525.

Intended Use: The Vanguard® Removable Molded Poly Tibia is intended for: 1. Painful and disabled knee joint resulting from osteoarthritis, rheumatoid arthritis traumatic arthritis where one or more compartments are involved;

    1. Failure of a previous joint replacement procedure
    1. Correction of varus, valgus, or post traumatic deformity:
    1. Correction or revision of unsuccessful osteotomy or arthrodesis.

The device is a sinqle use implant intended for use with bone cement.

{1}------------------------------------------------

K102580
p.2/2

Summary of Technologies:

The technological characteristics (material, design, and sizing) of the Vanguard® Removable Molded Poly Tibia are identical to the predicate devices. The only change made to the Vanquard® Removable Molded Poly Tibia from the predicate device K060525 is to the stem design; the new device has a fixed cruciate stem whereas the predicate has a fixed I-beam stem. Additional sizes to the tibial plate and bearing include 59mm, 87mm and 91mm, which are identical to the predicate devices in K915132. The material, locking mechanism, and bearing articulation remain identical to the predicate devices. Therefore, Biomet believes the Vanguard® Removable Molded Poly Tibia is substantially equivalent to the previously cleared devices.

Non-Clinical Testing:

Mechanical testing was previously performed to determine substantial equivalence and the following test reports were provided in the predicate 510(k): CoCr I-Beam Tray 80/20 Fatique Test Report, Removable Molded Tibia PS Post Fatigue Strength, 10mm PS Component - Intercondylar Polyethylene Thickness Analysis, Vanguard Removable Retention Test. The CoCr Cruciate Plate 80/20 Fatigue Test Report is also provided to further indicate the devices are functional within its intended use.

Clinical Testing:

No clinical testing was necessary for a determination of substantial equivalence.

{2}------------------------------------------------

Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services (HHS) in the USA. The logo features a stylized image of an eagle or bird with outstretched wings, symbolizing protection and care. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the bird, indicating the department's name and country.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002

Biomet Manufacturing Corp. % Ms. Tamara J. West Senior Regulatory Affairs Specialist 56 East Bell Drive P.O. Box 587 Warsaw, Indiana 465801

MAR - 3 2011

Re: K102580

Trade/Device Name: Vanguard® Removable Molded Poly Tibia

Regulation Number: 21 CFR 888.3560

Regulation Name: Knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis

  • Regulatory Class: II Product Code: JWH Dated: January 3, 2011 Received: January 7, 2011
    Dear Ms. West:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must

{3}------------------------------------------------

Page 2 - Ms. Tamara J. West

comply with all the Act's requirements, including, but not limited to: registration and listing (21) CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours.

Mark N. Melkerson Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

Indications for Use

510(k) Number (if known):_K102580

Device Name: The Vanquard® Removable Molded Poly Tibia

Indications For Use:

The Vanquard® Cruciate Molded Poly Tibia is intended for:

  1. Painful and disabled knee joint resulting from osteoarthritis, rheumatoid arthritis traumatic arthritis where one or more compartments are involved;

  2. Failure of a previous joint replacement procedure

  3. Correction of varus, valgus, or post traumatic deformity;

  4. Correction or revision of unsuccessful osteotomy or arthrodesis.

The device is a single use implant intended for use with bone cement.

Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use (21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

for M. Melkerson

(Division Sign-Off) (Division Sign-Off)
Division of Surgical, Orthopedic,
Division of Surgices Divisious Surges and Restorative Devices

Page 1 of 1

510(k) Number _

§ 888.3560 Knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis.

(a)
Identification. A knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis is a device intended to be implanted to replace a knee joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. This generic type of device includes prostheses that have a femoral component made of alloys, such as cobalt-chromium-molybdenum, and a tibial component or components and a retropatellar resurfacing component made of ultra-high molecular weight polyethylene. This generic type of device is limited to those prostheses intended for use with bone cement (§ 888.3027).(b)
Classification. Class II.